# Pharmaq Analytiq (Pharmaq Analytiq Limited)

Private limited company registered in Inverness, classed under “Veterinary activities”.

- Company number: SC267850
- Status: Active
- Type: Private limited company
- Incorporated: 13 May 2004
- Registered office: An Lochran, 10 Inverness Campus, Inverness, IV2 5NA
- Location: Inverness
- Activity: Veterinary activities

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Pharmaq Analytiq do?

Private limited company registered in Inverness, classed under “Veterinary activities”.

### How much turnover does Pharmaq Analytiq make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/pharmaq-analytiq-sc267850

### Is Pharmaq Analytiq profitable?

We haven't found a profit figure in Pharmaq Analytiq's latest filed accounts.

### How many people work at Pharmaq Analytiq?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/pharmaq-analytiq-sc267850

### Who runs and owns Pharmaq Analytiq?

Its directors are Nils Arne Grønlie, Benjamin Paul North, Trine Vatle. Its owners are shown to subscribers.

### Where is Pharmaq Analytiq based?

Its registered office is An Lochran, 10 Inverness Campus, Inverness, IV2 5NA, in Inverness.

### When was Pharmaq Analytiq founded?

Pharmaq Analytiq Limited was incorporated on 13 May 2004.

### Is Pharmaq Analytiq still trading?

The register lists Pharmaq Analytiq Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-06-19: Accounts for a small company made up to 31 December 2025
- 2026-02-03: Registered office address changed from 22 Carsegate Road Inverness IV3 8EX to An Lochran 10 Inverness Campus Inverness IV2 5NA on 3 February 2026
- 2025-10-08: Current accounting period extended from 30 November 2025 to 31 December 2025
- 2025-09-22: Accounts for a small company made up to 30 November 2024
- 2024-10-14: Accounts for a small company made up to 30 November 2023
- 2024-06-17: Amended full accounts made up to 30 November 2022
- 2024-06-07: Total exemption full accounts made up to 30 November 2022
- 2023-12-11: Notification of Zoetis Inc as a person with significant control on 1 July 2020
- 2023-12-11: Cessation of Pharmaq As as a person with significant control on 1 July 2020
- 2022-10-26: Total exemption full accounts made up to 30 November 2021
- 2022-01-27: Total exemption full accounts made up to 30 November 2020
- 2021-05-04: Resolutions (and 3 more like it since 4 June 2013)
- 2020-11-26: Current accounting period extended from 31 March 2020 to 30 November 2020
- 2020-09-15: Full accounts made up to 30 September 2019
- 2020-07-13: Appointment of Nils Arne Grønlie as a director on 1 July 2020
- 2020-07-13: Notification of Pharmaq As as a person with significant control on 1 July 2020
- 2020-07-13: Appointment of Dr Benjamin Paul North as a director on 1 July 2020
- 2020-07-13: Appointment of Trine Vatle as a director on 1 July 2020
- 2020-07-13: Termination of appointment of Hernan Rinaldo Pizarro Tonini as a director on 1 July 2020
- 2020-07-13: Termination of appointment of Christopher Graham Goodall Matthews as a director on 1 July 2020
- 2020-07-13: Termination of appointment of John William Marshall as a director on 1 July 2020
- 2020-07-13: Termination of appointment of Prism Cosec Limited as a secretary on 1 July 2020
- 2020-07-13: Previous accounting period shortened from 30 September 2020 to 31 March 2020
- 2020-07-13: Cessation of Benchmark Animal Health Group Limited as a person with significant control on 1 July 2020
- 2020-06-01: Statement of capital following an allotment of shares on 29 May 2020 · GBP 778,501

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/pharmaq-analytiq-sc267850